Thursday, April 18, 2024
HomeRecent ArticlesCambridge-based Invaio Sciences Acquired Peptyde Bio

Cambridge-based Invaio Sciences Acquired Peptyde Bio

Cambridge-based Invaio Sciences Acquired Peptyde Bio.The acquisition brings an established platform and IP portfolio that will enable Invaio to speed up the design and discovery of biologically active peptides that can protect crops from pests and disease in a more sustainable way.

Cambridge-based Invaio Sciences Acquired Peptyde Bio.The acquisition brings an established platform and IP portfolio that will enable Invaio to speed up the design and discovery of biologically active peptides that can protect crops from pests and disease in a more sustainable way.

Read also – NYC-based Qortex Secures $10m in Funding

Invaio’s pioneering innovation approach is designed to produce nature-positive solutions for farmers by combining new active ingredients that are better for the environment with breakthrough systems that protect and deliver these actives.

Ignacio Martinez, Founding CEO of Invaio said, “This acquisition adds Peptyde Bio’s portfolio of confirmed peptide lead candidates for use in crop protection to our existing pipeline. When combined with our innovative biological delivery systems, we are uniquely positioned to offer growers more natural, efficient and effective solutions to protect their crops, It’s a truly exciting time for Invaio and the industry as we accelerate the leap to more nature-positive solutions for farmers.”

Yajie Niu, Chief Science Officer at Invaio said, “We’re delighted to bring Peptyde Bio into the Invaio fold,”“This will further enhance Invaio’s AI discovery platform, enabling us to speed new biological actives into the hands of growers, and making Invaio’s the most advanced bioactive discovery platform and pipeline in the industry.”

Peptyde Bio was launched by the Danforth Technology Company (DTC), a subsidiary of the Donald Danforth Plant Science Center that facilitates early-stage development of startup companies based on technologies developed by Danforth Center scientists.

Read also – CA-based AI Startup Artisan AI Secures Additional Funding from a Sequoia Scout

Tom Laurita, PhD, CEO of Danforth Technology Company said, “One of the principal purposes of the Danforth Center and DTC is to quickly bring emerging technologies developed at the Center to the market , This acquisition by Invaio is the first exit for a DTC company and proves that our strategy is working.”

Czymmek, PhD, CTO of Peptyde Bio said, “Peptyde Bio has created a large pipeline of peptides with novel modes of action. We are looking forward to integrating our technology into the Invaio discovery engine and delivery platform,”.

About Invaio

Invaio Sciences, founded by Flagship Pioneering, is a bio platform company accelerating the leap to nature-positive agriculture. The company builds on advances in human health and digital innovation to develop biological technologies for crop health, enabling farmers to both improve yields and use more natural crop health solutions.

Read also – Brazil-based Emergent Cold LatAm Secures US$500M in Funding

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular